New hope for Alzheimer's? phase 3 trial of DMB-I begins
Disease control
Recruiting now
This study tests whether the drug DMB-I (latrepirdine) can improve thinking and memory in people with mild to moderate Alzheimer's dementia. About 450 adults aged 60-90 will take either DMB-I, a placebo, or an active comparator for 26 weeks. Researchers will compare changes in co…
Phase: PHASE3 • Sponsor: Bigespas LTD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC